# disease_key|disease_query|origin_disease_ids(optional)|inject_yaml(optional)
# Gold Standard Benchmark â€” 4 diseases across 3 therapeutic areas
#
# 1. Rheumatoid Arthritis (autoimmune)
#    Ground truth: methotrexate, tofacitinib, baricitinib, tocilizumab, rituximab, leflunomide, hydroxychloroquine, sulfasalazine
#
# 2. Multiple Sclerosis (autoimmune/neuro)
#    Ground truth: fingolimod, dimethyl fumarate, teriflunomide, natalizumab, ocrelizumab
#
# 3. Type 2 Diabetes (metabolic)
#    Ground truth: metformin, empagliflozin, pioglitazone, semaglutide, sitagliptin
#
# 4. Inflammatory Bowel Disease (autoimmune/GI)
#    Ground truth: infliximab, vedolizumab, ustekinumab, tofacitinib, azathioprine
#
multiple_sclerosis|multiple sclerosis|MONDO_0005301|
type_2_diabetes|type 2 diabetes|EFO_0001360|
inflammatory_bowel_disease|inflammatory bowel disease|EFO_0003767|
